Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $2.43B | $2.29B | +6.13% |
Cost of Revenue | $629.3M | $542.2M | +16.06% |
Net Income | $240.5M | $393.4M | -38.87% |
EPS (Basic) | $1.65 | $2.71 | -39.11% |
EPS (Diluted) | $1.64 | $2.70 | -39.26% |
SG&A Expense | $572.5M | $581.5M | -1.55% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $28.03B | $26.57B | +5.52% |
Current Assets | $7.63B | $6.76B | +12.87% |
Total Liabilities | $11.05B | $11.35B | -2.64% |
Current Liabilities | $5.3B | $3.22B | +64.37% |
Long-Term Debt | $4.55B | $6.29B | -27.68% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $259.3M | $553.2M | -53.13% |
Investing Cash Flow | $-47.3M | $-66M | +28.33% |
Financing Cash Flow | $-23M | $-439.6M | +94.77% |
D&A | $183.2M | $147.5M | +24.20% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Net Margin | 9.9% | — | — |
ROA | 0.9% | — | — |
Current Ratio | $1.44 | — | — |
Other companies in Biotechnology